Pharmachem Laboratories' Lactium ingredient can now be delivered in candy form.
Photo from Pharmachem Laboratories
Pharmachem Laboratories’ (Kearny, NJ) Lactium ingredient can now be delivered in candy form. Studies have shown that the ingredient, a patented milk casein hydrolysate, can relieve symptoms of stress as well as promote relaxation and sleep.
The company believes the new candy form will have widespread appeal. “The concept that drove this innovation is that even the thought of enjoying a hard candy exerts a calming effect of its own when consumed, making it a natural delivery form for an ingredient like Lactium,” said Mitch Skop, director of product development, Pharmachem, in a press release.
Pharmachem worked with manufacturer Hillside Candies (Hillside, NJ) to develop the individually wrapped, organic honey hard candies. Each piece of candy delivers 150 mg of Lactium. Pharmachem says it can be consumed during the day or the night without causing drowsiness.
Also read:
Dietary Supplements for Stress-Related Burnout
Milk Casein Formula May Alleviate Burnout
Rethinking Relaxation Ingredients with New Combinations, Product Types
Jennifer Grebow
Editor-in-Chief
Nutritional Outlook magazine
jennifer.grebow@ubm.com
Cracking the code: Advancements in calcium absorption and nutritional understanding
July 23rd 2024Recent research conducted by ILSI U.S. and Canada – a global, nonprofit federation dedicated to advancing precompetitive research in the food, nutrition and health realms – and partially funded by Balchem, has shed light on how to improve predictions of Ca bioavailability across different food matrices.
Yili to pilot Xampla’s microscopic natural biopolymer capsules for nutrient fortification
July 17th 2024Xampla, a manufacturer natural biopolymers, has announced a partnership with Yili Innovation Centre Europe to test and validate Xampla’s microscopic natural biopolymer capsules used to fortify a range of products with vitamins and nutrients.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.